Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells

Jinbin Wei1, Quanfang Huang2, Facheng Bai1

  • 1Guangxi Medical University, Nanning 530021, China.

Insights

Origanum vulgare didymin (OVD) effectively inhibits liver cancer cell growth and migration. This flavonoid induces apoptosis and cell cycle arrest by impacting key molecular pathways and mitochondrial function.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Natural compounds offer potential therapeutic avenues for cancer treatment.
  • Origanum vulgare is a medicinal herb with known bioactive constituents.

Purpose of the Study:

  • To investigate the anti-cancer effects of didymin isolated from Origanum vulgare (OVD) on human HepG2 liver carcinoma cells.
  • To elucidate the underlying molecular mechanisms of OVD-induced anti-cancer activity.

Main Methods:

  • Isolation and identification of didymin from Origanum vulgare.
  • Assessment of OVD's effects on HepG2 cell viability, clonogenicity, and migration.
  • Analysis of cell cycle progression and apoptosis induction.
  • Evaluation of mitochondrial membrane potential and cytochrome c release.
  • Investigation of signaling pathways, including ERK/MAPK, PI3K/Akt, and RKIP levels.

Main Results:

  • OVD significantly inhibited HepG2 cell viability, clonogenicity, and migration.
  • OVD induced G2/M phase cell cycle arrest by regulating cyclin B1, cyclin D1, and CDK4.
  • OVD promoted apoptosis via modulation of the Bcl-2/Bax ratio and caspase activation.
  • OVD attenuated mitochondrial membrane potential and induced cytochrome c release.
  • OVD inhibited ERK/MAPK and PI3K/Akt pathways by up-regulating RKIP.

Conclusions:

  • Origanum vulgare didymin (OVD) exhibits potent anti-cancer properties against HepG2 liver carcinoma cells.
  • OVD induces apoptosis and cell cycle arrest through mitochondrial dysfunction and inactivation of key signaling pathways.
  • Up-regulation of RKIP by OVD plays a crucial role in inhibiting ERK/MAPK and PI3K/Akt pathways.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K